Morgan Stanley Anebulo Pharmaceuticals, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 419,994 shares of ANEB stock, worth $806,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
419,994
Previous 399,219
5.2%
Holding current value
$806,388
Previous $770,000
8.44%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$29.7 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$5.83 Million0.26% of portfolio
-
Mangrove Partners New York, NY2.53MShares$4.85 Million0.66% of portfolio
-
Lvw Advisors, LLC633KShares$1.21 Million0.13% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$302,8220.04% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $49.2M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...